- Home
- / NeuroSense Therapeutics
NeuroSense Therapeutics
NeuroSense Therapeutics Summary
Company Summary
- Overview
- NeuroSense Therapeutics is a clinical-stage drug development company. It provides treatment for amyotrophic lateral sclerosis (ALS) as well as other neurodegenerative diseases.
- Type
- Private
- Status
- Active
- Founded
- 2017
- HQ
- Cambridge, MA, US | view all locations
- Cybersecurity rating
Table of Contents
LocationsView all
2 locations detected
Cambridge, MA HQ
United States
One Broadway
Herzliya, Tel Aviv District
Israel
Ha-Menofim 11
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2026